These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36482390)

  • 1. CT-based radiogenomic analysis dissects intratumor heterogeneity and predicts prognosis of colorectal cancer: a multi-institutional retrospective study.
    Zhong ME; Duan X; Ni-Jia-Ti MY; Qi H; Xu D; Cai D; Li C; Huang Z; Zhu Q; Gao F; Wu X
    J Transl Med; 2022 Dec; 20(1):574. PubMed ID: 36482390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiogenomic signatures reveal multiscale intratumour heterogeneity associated with biological functions and survival in breast cancer.
    Fan M; Xia P; Clarke R; Wang Y; Li L
    Nat Commun; 2020 Sep; 11(1):4861. PubMed ID: 32978398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiogenomic Signatures of Oncotype DX Recurrence Score Enable Prediction of Survival in Estrogen Receptor-Positive Breast Cancer: A Multicohort Study.
    Fan M; Cui Y; You C; Liu L; Gu Y; Peng W; Bai Q; Gao X; Li L
    Radiology; 2022 Mar; 302(3):516-524. PubMed ID: 34846204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour heterogeneity revealed by unsupervised decomposition of dynamic contrast-enhanced magnetic resonance imaging is associated with underlying gene expression patterns and poor survival in breast cancer patients.
    Fan M; Xia P; Liu B; Zhang L; Wang Y; Gao X; Li L
    Breast Cancer Res; 2019 Oct; 21(1):112. PubMed ID: 31623683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.
    Lin D; Fan W; Zhang R; Zhao E; Li P; Zhou W; Peng J; Li L
    J Transl Med; 2021 Jun; 19(1):279. PubMed ID: 34193202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Radiogenomic Risk Score: Construction of a Prognostic Quantitative, Noninvasive Image-based Molecular Assay for Renal Cell Carcinoma.
    Jamshidi N; Jonasch E; Zapala M; Korn RL; Aganovic L; Zhao H; Tumkur Sitaram R; Tibshirani RJ; Banerjee S; Brooks JD; Ljungberg B; Kuo MD
    Radiology; 2015 Oct; 277(1):114-23. PubMed ID: 26402495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
    Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
    Front Immunol; 2022; 13():994874. PubMed ID: 36330513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction.
    Qian Z; Li Y; Sun Z; Fan X; Xu K; Wang K; Li S; Zhang Z; Jiang T; Liu X; Wang Y
    Aging (Albany NY); 2018 Oct; 10(10):2884-2899. PubMed ID: 30362964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
    Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
    Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiogenomics to characterize the immune-related prognostic signature associated with biological functions in glioblastoma.
    Liu D; Chen J; Ge H; Yan Z; Luo B; Hu X; Yang K; Liu Y; Liu H; Zhang W
    Eur Radiol; 2023 Jan; 33(1):209-220. PubMed ID: 35881182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomogram Integrating Genomics with Clinicopathologic Features Improves Prognosis Prediction for Colorectal Cancer.
    Xiong Y; You W; Hou M; Peng L; Zhou H; Fu Z
    Mol Cancer Res; 2018 Sep; 16(9):1373-1384. PubMed ID: 29784666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
    Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
    PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mesenchymal-associated transcriptomic signature for risk-stratification and therapeutic response prediction in colorectal cancer.
    Matsuyama T; Kandimalla R; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kinugasa Y; Hansen TF; Fakih M; Uetake H; Győrffy B; Goel A
    Int J Cancer; 2020 Dec; 147(11):3250-3261. PubMed ID: 32657428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Size Deep Learning Based Preoperative Computed Tomography Signature for Prognosis Prediction of Colorectal Cancer.
    Li CH; Cai D; Zhong ME; Lv MY; Huang ZP; Zhu Q; Hu C; Qi H; Wu X; Gao F
    Front Genet; 2022; 13():880093. PubMed ID: 35646105
    [No Abstract]   [Full Text] [Related]  

  • 16. Sexually dimorphic radiogenomic models identify distinct imaging and biological pathways that are prognostic of overall survival in glioblastoma.
    Beig N; Singh S; Bera K; Prasanna P; Singh G; Chen J; Saeed Bamashmos A; Barnett A; Hunter K; Statsevych V; Hill VB; Varadan V; Madabhushi A; Ahluwalia MS; Tiwari P
    Neuro Oncol; 2021 Feb; 23(2):251-263. PubMed ID: 33068415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer.
    Jiang L; You C; Xiao Y; Wang H; Su GH; Xia BQ; Zheng RC; Zhang DD; Jiang YZ; Gu YJ; Shao ZM
    Cell Rep Med; 2022 Jul; 3(7):100694. PubMed ID: 35858585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
    Chang W; Gao X; Han Y; Du Y; Liu Q; Wang L; Tan X; Zhang Q; Liu Y; Zhu Y; Yu Y; Fan X; Zhang H; Zhou W; Wang J; Fu C; Cao G
    Gut; 2014 Sep; 63(9):1457-67. PubMed ID: 24173294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiogenomic Analysis Demonstrates Associations between (18)F-Fluoro-2-Deoxyglucose PET, Prognosis, and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
    Yamamoto S; Huang D; Du L; Korn RL; Jamshidi N; Burnette BL; Kuo MD
    Radiology; 2016 Jul; 280(1):261-70. PubMed ID: 27082783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer.
    Lee J; Li B; Cui Y; Sun X; Wu J; Zhu H; Yu J; Gensheimer MF; Loo BW; Diehn M; Li R
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1098-1106. PubMed ID: 29439884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.